Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Nesfatin-1: functions and physiology of a novel regulatory peptide

Riccardo Dore, Hendrik Lehnert, Carla Schulz, Luka Levata

Abstract

Nesfatin-1 was identified in 2006 as a potent anorexigenic peptide involved in the regulation of homeostatic feeding. It is processed from the precursor-peptide NEFA/nucleobindin 2 (NUCB2), which is expressed both in the central nervous system as well as in the periphery, from where it can access the brain via non-saturable transmembrane diffusion. In hypothalamus and brainstem, nesfatin-1 recruits the oxytocin, the melancortin and other systems to relay its anorexigenic properties. NUCB2/nesfatin-1 peptide expression in reward-related areas suggests that nesfatin-1 might also be involved in hedonic feeding. Besides its initially discovered anorexigenic properties, over the last years, other important functions of nesfatin-1 have been discovered, many of them related to energy homeostasis, e.g. energy expenditure and glucose homeostasis. Nesfatin-1 is not only affecting these physiological processes but also the alterations of the metabolic state (e.g. fat mass, glycemic state) have an impact on the synthesis and release of NUCB2 and/or nesfatin-1. Furthermore, nesfatin-1 exerts pleiotropic actions at the level of cardiovascular and digestive systems, as well as plays a role in stress response, behavior, sleep and reproduction. Despite the recent advances in nesfatin-1 research, a putative receptor has not been identified and furthermore potentially distinct functions of nesfatin-1 and its precursor NUCB2 have not been dissected yet. To tackle these open questions will be the major objectives of future research to broaden our knowledge on NUCB2/nesfatin-1.
OriginalspracheEnglisch
ZeitschriftJournal of Endocrinology
Jahrgang232
Ausgabenummer1
Seiten (von - bis)R45-R65
Seitenumfang21
ISSN0022-0795
DOIs
PublikationsstatusVeröffentlicht - 01.2017

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

DFG-Fachsystematik

  • 2.22-17 Endokrinologie, Diabetologie, Metabolismus
  • SFB/Transregio TRR 134: Essverhalten - Homöostase und Belohnungssysteme

    Lehnert, H. (Sprecher*in), Brüning, J. C. (Projektleiter*in (PI)), Scholz, H. (Projektleiter*in (PI)), Kloppenburg, P. (Projektleiter*in (PI)), Hausen, A. C. (Projektleiter*in (PI)), Jöhren, O. (Projektleiter*in (PI)), Schulz, C. (Projektleiter*in (PI)), Schwaninger, M. (Projektleiter*in (PI)), Wunderlich, F. T. (Projektleiter*in (PI)), Schmid, S. (Projektleiter*in (PI)), Oster, H. (Projektleiter*in (PI)), Klement, J. (Projektleiter*in (PI)), Ott, V. (Projektleiter*in (PI)), Stephan, K. E. (Projektleiter*in (PI)), Tittgemeyer, M. (Projektleiter*in (PI)), Oltmanns, K. (Projektleiter*in (PI)), Münte, T. (Projektleiter*in (PI)), Tronnier, V. M. (Projektleiter*in (PI)), Schweiger, U. (Projektleiter*in (PI)), Brassen, S. (Projektleiter*in (PI)), Büchel, C. (Projektleiter*in (PI)), Peters, J. (Projektleiter*in (PI)), Schilbach, L. (Projektleiter*in (PI)), Anders, S. (Projektleiter*in (PI)), Martinetz, T. (Projektleiter*in (PI)), Park, S. Q. (Projektleiter*in (PI)), Brabant, E. G. (Projektleiter*in (PI)), Kasten, M. (Projektleiter*in (PI)), Klein, C. (Projektleiter*in (PI)) & Krämer, U. (Projektleiter*in (PI))

    01.01.1431.12.18

    Projekt: DFG VerbundprojekteDFG Sonderforschungsbereiche / Transregios (SFB/TR)

Zitieren